Drug Approval | October 19, 2022
USFDA visit to Alembic Pharmaceuticals Panelav facility
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
None of the observations are related to data integrity and Alembic Pharmaceuticals management believes that they are addressable
He is a seasoned business leader with a successful track record of over 26 years across local and area roles within the pharmaceutical industry
Both the partners will work towards bringing Aster Pharmacy’s in-house quality care products to serve the healthcare needs of the local population in KSA
For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR
Since FY 2020 till FY 2022, the organisation has reduced energy consumption by 9.2%
Agreement strengthens Evonik’s track record as leading contract development and manufacturing organization (CDMO)
This clinical study aims to evaluate the efficacy of JAB-21822 in combination with cetuximab in patients with KRAS G12C-mutated colorectal cancer.
ADCelerate delivers Phase I appropriate antibody-drug conjugate (ADC) drug substance and drug product for Investigational New Drug (IND) submission
The company increases its efficiency and is able to face the growing demand for its services.
DSCO has requested WHO to share at the earliest with CDSCO the report on establishment of causal relation to death with the medical products in question etc.
Subscribe To Our Newsletter & Stay Updated
